APO 131 (Carbidopa and levodopa extended release 25 mg / 100 mg)

Pill imprint APO 131 has been identified as Carbidopa and levodopa extended release 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa extended release

Imprint:

APO 131

Strength:

25 mg / 100 mg

Color:

Red

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Apotex Corp.

National Drug Code (NDC):

60505-0131

Inactive Ingredients:

hypromelloses
magnesium stearate
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.